BioCentury | Apr 18, 2016
Financial News

Stat-Diagnostica and Innovation completes venture financing

Stat-Diagnostica and Innovation , Barcelona, Spain Business: Diagnostic Date completed: 2016-04-11 Type: Venture financing Raised: EUR25 million ($28.4 million) Investors: Gilde Healthcare Partners; Kurma Partners; Ysios Capital Partners; Idinvest Partners; Boehringer Ingelheim Venture Fund; Caixa Capital;...
BioCentury | Jun 24, 2013
Company News

Stat-Diagnostica and Innovation board of directors update

Stat-Diagnostica and Innovation , Barcelona, Spain Business: Diagnostic Appointed: Gerard Vaillant as chairman WIR Staff...
BioCentury | May 13, 2013
Financial News

Stat-Diagnostica and Innovation completes venture financing

Stat-Diagnostica and Innovation , Barcelona, Spain Business: Diagnostic Date completed: 5/6/13 Type: Venture financing Raised: $22.1 million Investors: Kurma Life Sciences Partners; Idinvest Partners; Boehringer Ingelheim Venture Fund; Caixa Capital; Ysios Capital Partners; Axis Participaciones Empresariales...
BioCentury | May 13, 2013
Finance

Dx-ing Dx investing

...position," Droller said. KLS last week participated in a $22.1 million series B round by Stat-Diagnostica and Innovation...
...Inc. (NYSE:DGX), Madison, N.J. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sequenom Inc. (NASDAQ:SQNM), San Diego, Calif. Stat-Diagnostica and Innovation...
BioCentury | May 7, 2013
Financial News

Stat-Diagnostica raises $22.1 million in series B

Stat-Diagnostica and Innovation (Barcelona, Spain) raised $22.1 million in a series B round led by new investor Kurma Life Sciences Partners. New investors Idinvest Partners; Boehringer Ingelheim Venture Fund; and Caixa Capital also participated, along...
Items per page:
1 - 5 of 5
BioCentury | Apr 18, 2016
Financial News

Stat-Diagnostica and Innovation completes venture financing

Stat-Diagnostica and Innovation , Barcelona, Spain Business: Diagnostic Date completed: 2016-04-11 Type: Venture financing Raised: EUR25 million ($28.4 million) Investors: Gilde Healthcare Partners; Kurma Partners; Ysios Capital Partners; Idinvest Partners; Boehringer Ingelheim Venture Fund; Caixa Capital;...
BioCentury | Jun 24, 2013
Company News

Stat-Diagnostica and Innovation board of directors update

Stat-Diagnostica and Innovation , Barcelona, Spain Business: Diagnostic Appointed: Gerard Vaillant as chairman WIR Staff...
BioCentury | May 13, 2013
Financial News

Stat-Diagnostica and Innovation completes venture financing

Stat-Diagnostica and Innovation , Barcelona, Spain Business: Diagnostic Date completed: 5/6/13 Type: Venture financing Raised: $22.1 million Investors: Kurma Life Sciences Partners; Idinvest Partners; Boehringer Ingelheim Venture Fund; Caixa Capital; Ysios Capital Partners; Axis Participaciones Empresariales...
BioCentury | May 13, 2013
Finance

Dx-ing Dx investing

...position," Droller said. KLS last week participated in a $22.1 million series B round by Stat-Diagnostica and Innovation...
...Inc. (NYSE:DGX), Madison, N.J. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sequenom Inc. (NASDAQ:SQNM), San Diego, Calif. Stat-Diagnostica and Innovation...
BioCentury | May 7, 2013
Financial News

Stat-Diagnostica raises $22.1 million in series B

Stat-Diagnostica and Innovation (Barcelona, Spain) raised $22.1 million in a series B round led by new investor Kurma Life Sciences Partners. New investors Idinvest Partners; Boehringer Ingelheim Venture Fund; and Caixa Capital also participated, along...
Items per page:
1 - 5 of 5